June 20, 2017

2016 National Progress Report Points to New Tools to Combat Opioid Abuse

Claiming the lives of 91 Americans each day, America’s opioid epidemic is a national public health crisis.i State governments are increasingly taking action through a combination of public policy, technology adoption and education initiatives, as evidenced by the surge of mandates across the country. Surescripts 2016 National Progress Report shows that while e-prescribing is one of the most powerful tools available to fight prescription painkiller fraud and abuse, there are many factors at play.

Controlling Access to Opioids: Pill Counts Matter

The sheer number of opioid pills prescribed in the U.S. annually is staggering. In 2016, pharmacies received 3.71 million e-prescriptions for opioid drugs: 1.73 million for oxycodone-containing medications and 1.98 million for hydrocodone-containing medications. These prescriptions accounted for more than 307 million tablets ordered, and averaged 82.9 tablets per prescription.

An initiative announced by the Obama Administration in March 2015 to combat the opioid epidemic and save lives included a strategy to decrease the volume of pills per prescription. Yet data from the 2016 National Progress Report found that the average pill quantity decreased only slightly last year, from 84.6 per prescription in January to 82.8 per prescription in December.

The largest decrease in pill quantity occurred from March to April, which is when a state mandate for e-prescribing, known as the Internet System for Tracking Over-Prescribing (I-STOP), went into effect in New York. In 2017, we anticipate a greater decrease in pill quantity, as more physicians and pharmacies use e-prescribing for controlled substances and adhere to best practice guidelines.

Naloxone: A Powerful Antidote

The 2016 National Progress Report also highlights promising results in the prescribing of naloxone, a treatment that quickly reverses the effects of opioid overdose and saves thousands of lives each year. It’s now widely available to first responders in communities with high rates of overdose, and many major pharmacies offer it without a prescription for easy access in emergency situations.

Recent FDA-approved dosage formulations for the drug, including a nasal spray and an auto-injector, are easier to administer outside of a hospital setting. In 2016, we found that nearly 50% of naloxone therapy e-prescriptions were for the auto-injector formulation, and 33% were for the nasal spray formulation.

In addition to making naloxone available in more accessible forms, public education is also contributing to greater use. Following President Obama’s signing of the Comprehensive Addiction and Recovery Act (CARA) in July 2016, an education campaign launched by the federal government led to major media attention and a significant increase in the volume of e-prescriptions for naloxone across all three dosage formulations. After the bill passed, there were 3,779 naloxone prescriptions in August—80% higher than the monthly average.

As the battle against opioid abuse in the U.S. continues, data from the 2016 National Progress Report offers hope that more progress can be made with the solutions that are available today. For a comprehensive overview of our nation’s opioid epidemic, as well as video interviews on how controlling pill volume and naloxone prescriptions can help fight the epidemic, check out the complete 2016 National Progress Report. Also, visit GetEPCS.com for more information on how physicians and pharmacies can deploy EPCS solutions.

i Centers for Disease Control and Prevention (CDC): https://www.cdc.gov/drugoverdose/epidemic/

YOU MIGHT ALSO LIKE

July 05, 2018

Key Technologies for Fighting Opioid Misuse are Gaining Traction

The statistics are staggering. According to the Centers for Disease Control and Prevention, the opioid epidemic now takes more lives in the U.S. than breast cancer. In addition, American life expectancy at birth declined for the second consecutive year in 2016 due to a dramatic 21 percent rise in the death rate from drug overdoses. Our nation has not experienced a two-year consecutive decline in life expectancy since the early 1960s as a result of an influenza epidemic. Even the worst mortality rate of the AIDS epidemic in 1993 caused American life expectancy to drop for just one year. Read more...

July 02, 2018

Maine Required E-Prescribing for Opioids Last Year—and the Results Are In

This time last year, Maine implemented legislation that requires electronic prescribing for opioids. At the time, Maine ranked 25th in the nation based on prescriber and pharmacist enablement and utilization of the technology, known as E-Prescribing for Controlled Substances (EPCS). Now the state is ranked third in the nation, with virtually all its pharmacies and more than half of all its prescribers enabled for the technology as of May 2018. New York leads the nation, having implemented a legislative requirement in 2016 that requires all prescriptions to be delivered electronically, including controlled substances. Read more...

June 20, 2018

Surescripts Supports Healthcare Leadership Council’s “Roadmap for Action” to Address Opioid Crisis

Today, Surescripts joined more than 70 healthcare organizations in supporting the Healthcare Leadership Council’s “Roadmap for Action” offering guidance for healthcare professionals, lawmakers and regulators to address the opioid crisis. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX